CCEP vs KO: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
KO is the larger of the two ($414.25B market cap): the incumbent the market prices for continued execution (27.30x forward earnings, beta 0.27). CCEP is the smaller challenger ($51.28B), cheaper on forward earnings (21.09x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
CCEP vs KO: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | CCEP | KO | What it tells you |
|---|---|---|---|
| Market cap | $51.28B | $414.25B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 21.09 | 27.30 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 22.57 | 28.41 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.46 | 0.27 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 94% of range | 96% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 5.57 | 11.08 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: CCEP is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how CCEP and KO affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CCEP and KO share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CCEP and KO exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Coca-Cola Europacific Partners (CCEP) do?
Coca-Cola Europacific Partners makes, packages, sells and delivers non-alcoholic ready-to-drink beverages under licence from The Coca-Cola Company and a handful of partner brand owners. Its portfolio spans Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Monster Energy, Costa Coffee ready-to-drink, Powerade, Capri-Sun, Vitaminwater, Smartwater and, in Australia and the Pacific, the former Amatil brands. The territory list runs across Western Europe (Great Britain, Germany, Spain, France, Belgium, the Netherlands, Portugal, Norway, Sweden, Iceland and smaller markets) plus an Asia Pacific segment built from the 2021 acquisition of Coca-Cola Amatil, which brought Australia, New Zealand, Indonesia, Papua New Guinea and Fiji, and the 2024 purchase of a 60% stake in Coca-Cola Beverages Philippines alongside Aboitiz Equity Ventures. Around ~37,000 employees run the plants, warehouses and route-to-market fleets that reach several hundred million consumers. Ownership is concentrated: Olive Partners, tied to the Daurella family, holds roughly ~36%, and The Coca-Cola Company itself holds roughly ~17%.
What does Coca-Cola (KO) do?
The Coca-Cola Company is the world's largest non-alcoholic beverage company, built around a portfolio of more than 200 brands sold in over 200 countries. Its lineup spans sparkling soft drinks (Coca-Cola, Sprite, Fanta), water and sports drinks (Dasani, smartwater, Powerade, BODYARMOR), juices and dairy (Minute Maid, Simply, fairlife), coffee (Costa), and tea. Coca-Cola operates primarily as a brand owner and concentrate maker: it sells concentrates and syrups to a global network of independent and company-affiliated bottlers, who add water and packaging and handle local distribution. This asset-light model keeps Coca-Cola's margins high and capital needs low while the bottlers carry the heavier manufacturing and logistics costs. The company makes money through the spread on concentrate sales plus brand licensing and marketing scale. Founded in 1886 and headquartered in Atlanta, Georgia, Coca-Cola is a Dividend King with one of the longest continuous dividend-increase records of any public company, and a long-standing core holding of Berkshire Hathaway.
CCEP vs KO: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- CCEP drivers: Asia Pacific scale, with the Philippines as the swing factor; Revenue growth management rather than volume heroics.
- KO drivers: Unmatched global brand and distribution; Portfolio diversification beyond soda.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Currency is the first thing a US shareholder should understand: CCEP reports in euros while the Nasdaq line quotes in dollars, so a weaker euro compresses reported dollar returns even when the underlying business is fine, and the group also carries Australian dollar, sterling, rupiah and peso translation exposure. For KO, coca-Cola faces secular pressure on sugary sodas from health trends, sugar taxes, and regulation in many markets.
CCEP or KO: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CCEP if you believe its drivers more; KO if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CCEP and KO guides.
CCEP vs KO: the full fundamentals
CCEP. Reported figures are in euros while the Nasdaq line quotes in dollars, so headline conversions move with the exchange rate rather than with trading. After a ~27% year-to-date rise to ~$112.29 on 16 October 2026, CCEP trades at about ~21.7x trailing and ~20.4x forward earnings, slightly above the ~$109.68 mean analyst target, though still at a discount to The Coca-Cola Company. A payout ratio under half of earnings and a ~2.2% yield keep the defensive character, with the Q3 trading update the next datapoint.
KO. Coca-Cola trades at a premium to the typical staple, and the 2026 rally has stretched it: about 28x trailing and 27x forward earnings as of October 2026, with the yield compressed to about 2.3% from roughly 3% earlier in the year. The multiple embeds steady mid-single-digit organic growth and reliable cash returns, supported by four consecutive EPS beats. Q3 results on October 27 (consensus about $0.88 EPS on $12.9 billion of revenue) are the next test.
Headline figures (approximate, October 2026): CCEP shows revenue (ttm) ~EUR 21.4bn (latest qtr ~4.4% YoY), operating / net margin (ttm) ~13.4% / ~9.4%, net income / diluted eps (ttm) ~2.0bn, ~$5.18 per share, market cap ~$49.3bn; KO shows revenue (ttm) ~$50.1 billion, revenue growth (q2 2026, yoy) ~+6.7%, operating margin ~35% (high, a product of the asset-light concentrate model), net income (ttm) ~$14.3 billion.
The bottom line: CCEP vs KO
CCEP and KO are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CCEP and KO exposure against your real portfolio. It is not an investment adviser.
Wondering how CCEP or KO fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Coca-Cola Europacific Partners
Ask Walnut's AI anything about CCEP and see how it fits what you own.
FAQ
What is the difference between CCEP and KO?
+
Coca-Cola Europacific Partners makes, packages, sells and delivers non-alcoholic ready-to-drink beverages under licence from The Coca-Cola Company and a handful of partner brand owners. The Coca-Cola Company is the world's largest non-alcoholic beverage company, built around a portfolio of more than 200 brands sold in over 200 countries. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is CCEP or KO the better stock?
+
Neither is universally better. KO is the larger incumbent; CCEP is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, CCEP or KO?
+
On forward P/E (as of November 2026), CCEP trades at 21.09x and KO at 27.30x, so CCEP is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both CCEP and KO?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of CCEP vs KO?
+
CCEP: Currency is the first thing a US shareholder should understand: CCEP reports in euros while the Nasdaq line quotes in dollars, so a weaker euro compresses reported dollar returns even when the underlying business is fine, and the group also carries Australian dollar, sterling, rupiah and peso translation exposure. Leverage is real, with roughly ~12.2bn of gross debt against ~2.0bn of cash and a debt-to-equity ratio near ~1.39, a legacy of financing the Amatil and Philippines acquisitions. Regulation is a standing headwind rather than an event: sugar levies across the UK, Ireland, Spain, Portugal and elsewhere, extended producer responsibility fees on packaging, deposit return schemes and the EU Packaging and Packaging Waste Regulation all raise the cost of putting a drink on a shelf. The whole business also depends on bottling and distribution agreements with The Coca-Cola Company, which owns roughly ~17% of CCEP and sets concentrate pricing, so the economics are negotiated rather than sovereign. Product-quality events can be expensive and public, as in January 2025 when CCEP recalled Coca-Cola and related products produced at its Ghent plant across Belgium, the Netherlands, Luxembourg, France, Germany and Great Britain after elevated chlorate levels were detected. Valuation is now a risk in its own right: after a ~27% rise in 2026 the shares trade above the ~$109.68 mean analyst target, so a softer Q3 or a volume slowdown of the kind Jefferies flagged in October could weigh on the multiple. As of August 2026 no active US securities-fraud class action against CCEP was identified, and the company filed its FY2025 Form 20-F in March 2026 with continuing routine 6-K filings, with no Form 25 or delisting process in evidence. Walnut is not an investment adviser; this page describes the business and is not a recommendation. KO: Coca-Cola faces secular pressure on sugary sodas from health trends, sugar taxes, and regulation in many markets. Heavy international exposure makes reported results sensitive to a strong US dollar, which can mask solid underlying growth. Slow overall organic growth means the stock trades like a bond proxy, vulnerable when interest rates rise. Valuation is now a risk in itself: after a ~35% gain in 2026 the shares trade near 28x trailing and 27x forward earnings, close to the mean analyst target of about $95, which leaves less room for a disappointing quarter. Total debt of about $44 billion is higher than cash of roughly $16 billion. Input-cost inflation (sweeteners, aluminum, packaging) and litigation or regulatory scrutiny over sugar and plastics are ongoing risks. Competition from PepsiCo, private label, and a long tail of niche beverage brands caps share gains in developed markets.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CCEP or KO; figures are approximate and dated (as of November 2026). Verify current data before investing.